• About
  • Partnerships
  • Challenges
  • Awards
  • Grant Opportunities
  • News

Low Cost, SIngle Dose, Oral, Live Ad4-based VP Polio Vaccine

Kenneth Kelley of PaxVax in the U.S. seeks to develop a low-cost, single-dose, oral polio vaccine using a live, safe adenovirus containing protein-encoding genes from poliovirus. If successful, this vaccine can be used to eradicate polio while eliminating the risks of vaccine-derived polio disease and poliovirus re-introduction.

More information about The Poliovirus Endgame: Create ways to Accelerate, Sustain and Monitor Eradication (Round 6)

Great ideas come from everywhere.

Sign up for email updates of the latest grant opportunities and awards.

View the Grand Challenges partnership network

The Bill & Melinda Gates Foundation is part of the Grand Challenges partnership network. Visit www.grandchallenges.org to view the map of awarded grants across this network and grant opportunities from partners.